In today’s session Davita Inc (DVA) registered an unusually high (136) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the December, 2016 call, expecting serious DVA increase. With 136 contracts traded and 10464 open interest for the Dec, 16 contract, it seems this is a quite bullish bet. The option with symbol: DVA161216C00065000 closed last at: $0.9 or 12.5% up. About 229,070 shares traded hands. Davita Inc (NYSE:DVA) has declined 15.41% since April 22, 2016 and is downtrending. It has underperformed by 20.82% the S&P500.
Analysts await Davita Inc (NYSE:DVA) to report earnings on February, 9. They expect $0.91 earnings per share, down 9.90% or $0.10 from last year’s $1.01 per share. DVA’s profit will be $180.56M for 17.39 P/E if the $0.91 EPS becomes a reality. After $0.95 actual earnings per share reported by Davita Inc for the previous quarter, Wall Street now forecasts -4.21% negative EPS growth.
Davita Inc (NYSE:DVA) Ratings Coverage
Out of 6 analysts covering DaVita (NYSE:DVA), 1 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 17% are positive. DaVita has been the topic of 11 analyst reports since August 6, 2015 according to StockzIntelligence Inc. The rating was initiated by JP Morgan with “Neutral” on Wednesday, September 16. The firm has “Sector Perform” rating by RBC Capital Markets given on Wednesday, November 4. The firm has “Neutral” rating by Citigroup given on Tuesday, September 6. On Tuesday, August 9 the stock rating was maintained by JP Morgan with “Neutral”. The rating was maintained by Bernstein on Wednesday, March 2 with “Market Perform”. The firm has “Sector Perform” rating by RBC Capital Markets given on Tuesday, February 16. Raymond James upgraded the stock to “Outperform” rating in Tuesday, September 20 report. Bank of America downgraded the stock to “Neutral” rating in Tuesday, September 6 report. The rating was maintained by RBC Capital Markets with “Sector Perform” on Thursday, August 6.
According to Zacks Investment Research, “DaVita Inc. is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a provider of kidney care, delivering dialysis services for chronic kidney failure and end stage renal disease primarily in the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks primarily in California, Nevada, New Mexico, Florida, Colorado and Washington. DaVita Inc., formerly known as DaVita HealthCare Partners Inc., is headquartered in Denver, Colorado.”
Insitutional Activity: The institutional sentiment increased to 1.16 in Q2 2016. Its up 0.12, from 1.04 in 2016Q1. The ratio is positive, as 34 funds sold all Davita Inc shares owned while 162 reduced positions. 51 funds bought stakes while 153 increased positions. They now own 171.18 million shares or 3.23% less from 176.89 million shares in 2016Q1.
Huntington Bancorporation has 293 shares for 0% of their US portfolio. Lombard Odier Asset Mgmt (Europe) Ltd holds 0.01% of its portfolio in Davita Inc (NYSE:DVA) for 3,283 shares. Arizona State Retirement Sys holds 0.1% of its portfolio in Davita Inc (NYSE:DVA) for 89,986 shares. Commercial Bank Of America Corporation De reported 504,328 shares or 0.01% of all its holdings. Moreover, Sumitomo Mitsui Tru has 0.07% invested in Davita Inc (NYSE:DVA) for 508,512 shares. Ironwood Inv Management Limited Liability has 0.17% invested in the company for 2,996 shares. Comerica National Bank & Trust owns 82,457 shares or 0.05% of their US portfolio. The United Kingdom-based Hsbc Holdg Public Limited has invested 0.05% in Davita Inc (NYSE:DVA). Guggenheim Capital Ltd Liability Co last reported 431,774 shares in the company. Diam, a Japan-based fund reported 150,901 shares. Moreover, Prudential Pcl has 0.03% invested in Davita Inc (NYSE:DVA) for 88,200 shares. Advantus Capital has invested 0.03% of its portfolio in Davita Inc (NYSE:DVA). Lpl Finance Ltd Liability last reported 6,056 shares in the company. Citigroup Inc has 0.01% invested in the company for 143,807 shares. Creative Planning holds 0% or 3,960 shares in its portfolio.
Insider Transactions: Since July 1, 2016, the stock had 0 insider purchases, and 3 sales for $1.94 million net activity. JIGANTI JEANINE MARIE had sold 1,291 shares worth $101,360 on Monday, July 11. STAFFIERI MICHAEL DAVID sold $1.48M worth of stock or 20,262 shares.
DaVita Inc., formerly DaVita HealthCare Partners Inc., is a well-known provider of kidney care services. The company has a market cap of $12.56 billion. The Firm operates Kidney Care division and HealthCare Partners division. It has a 18.31 P/E ratio. The Company’s divisions include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives.
DVA Company Profile
DaVita Inc., formerly DaVita HealthCare Partners Inc., incorporated on April 4, 1994, is a well-known provider of kidney care services. The Firm operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s divisions include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. The Company’s Kidney Care division is a well-known provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD). HCP division is a patient and physician-focused integrated health care delivery and management company.
More news for Davita Inc (NYSE:DVA) were recently published by: Prnewswire.com, which released: “DaVita Inc. 3rd Quarter 2016 Results” on November 02, 2016. Prnewswire.com‘s article titled: “DaVita Clinical Research to Present 12 Abstracts at American Society of …” and published on November 14, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.